Health authorities warn public against counterfeit COVID-19 drugs | ABS-CBN
ADVERTISEMENT

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Health authorities warn public against counterfeit COVID-19 drugs
Health authorities warn public against counterfeit COVID-19 drugs
Job Manahan,
ABS-CBN News
Published Jan 19, 2022 08:58 PM PHT

MANILA — Health authorities on Wednesday warned the public about the spread of fake COVID-19 oral treatments such as molnupiravir, advising them not to buy medicines from unauthorized sources, noting the possible health hazards of these drugs.
MANILA — Health authorities on Wednesday warned the public about the spread of fake COVID-19 oral treatments such as molnupiravir, advising them not to buy medicines from unauthorized sources, noting the possible health hazards of these drugs.
In a statement, the Department of Health (DOH) said it received reports about "possible" counterfeit versions of the antiviral drug molnupiravir.
In a statement, the Department of Health (DOH) said it received reports about "possible" counterfeit versions of the antiviral drug molnupiravir.
"Remember, there is no guarantee that molnupiravir sold from unauthorized sources are genuine and purchasing of such products may pose serious health risks for the consumer," the DOH statement read.
"Remember, there is no guarantee that molnupiravir sold from unauthorized sources are genuine and purchasing of such products may pose serious health risks for the consumer," the DOH statement read.
"It is your physician who will help secure your medicines and ensure they are authentic by referring you to authorized sellers," the agency added.
"It is your physician who will help secure your medicines and ensure they are authentic by referring you to authorized sellers," the agency added.
ADVERTISEMENT
The Food and Drug Administration (FDA) had previously released a statement condemning the "growing sales" for the investigational COVID-19 treatment through "unlicensed" sellers.
The Food and Drug Administration (FDA) had previously released a statement condemning the "growing sales" for the investigational COVID-19 treatment through "unlicensed" sellers.
The drug regulator last month approved Molnarz's molnupiravir for emergency use in treating COVID-19 cases.
The drug regulator last month approved Molnarz's molnupiravir for emergency use in treating COVID-19 cases.
The DOH said molnupiravir could only be used "under the supervision of a licensed physician" and in certain conditions.
The DOH said molnupiravir could only be used "under the supervision of a licensed physician" and in certain conditions.
"Molnupiravir is safe and effective when used in the correct patients and administered for no more than 5 days," the statement read.
"Molnupiravir is safe and effective when used in the correct patients and administered for no more than 5 days," the statement read.
"Using the drug improperly can cause harm, especially if it is used in the wrong target population, for longer than 5 days, or in patients who do not have confirmed COVID-19 infection," it added.
"Using the drug improperly can cause harm, especially if it is used in the wrong target population, for longer than 5 days, or in patients who do not have confirmed COVID-19 infection," it added.
ADVERTISEMENT
The FDA reminded the public that the EUA prohibits the sale of molnupiravir commercially, which is why it is possible that some establishments selling it online are illicit sellers.
The FDA reminded the public that the EUA prohibits the sale of molnupiravir commercially, which is why it is possible that some establishments selling it online are illicit sellers.
"Buying medicines in unlicensed establishments or over the internet can pose serious health risks. Furthermore, a medicine bought in an unlicensed establishment or online cannot be guaranteed as genuine and may contain no active ingredient, too much or too little active ingredient which may result in the condition/ailments not being treated correctly," the agency said.
"Buying medicines in unlicensed establishments or over the internet can pose serious health risks. Furthermore, a medicine bought in an unlicensed establishment or online cannot be guaranteed as genuine and may contain no active ingredient, too much or too little active ingredient which may result in the condition/ailments not being treated correctly," the agency said.
PAXLOVID
Infectious disease expert Dr. Edsel Salvana, meanwhile, advised the public against the unauthorized use of Pfizer's oral antiviral treatment Paxlovid.
Infectious disease expert Dr. Edsel Salvana, meanwhile, advised the public against the unauthorized use of Pfizer's oral antiviral treatment Paxlovid.
Paxlovid is nearly 90 percent effective in preventing hospitalizations and death rates, and data suggested it retains its effectiveness against the omicron variant, Pfizer has said.
Paxlovid is nearly 90 percent effective in preventing hospitalizations and death rates, and data suggested it retains its effectiveness against the omicron variant, Pfizer has said.
The COVID-19 pill when used with viagra "and similar erectile dysfunction (ED) drugs," Salvana said, could cause prolonged erection, among other things.
The COVID-19 pill when used with viagra "and similar erectile dysfunction (ED) drugs," Salvana said, could cause prolonged erection, among other things.
ADVERTISEMENT
"Mixing Paxlovid with Viagra and similar erectile dysfunction (ED) drugs can result in unpredictably high levels of the ED drug resulting in low blood pressure, and unsafe levels of... prolonged erection," he said in a Facebook post.
"Mixing Paxlovid with Viagra and similar erectile dysfunction (ED) drugs can result in unpredictably high levels of the ED drug resulting in low blood pressure, and unsafe levels of... prolonged erection," he said in a Facebook post.
"The ritonavir component of this drug has multiple potentially unsafe drug interactions, including interactions with some anticholesterol drugs (statins), steroids, rifampicin (used for tuberculosis)" he added.
"The ritonavir component of this drug has multiple potentially unsafe drug interactions, including interactions with some anticholesterol drugs (statins), steroids, rifampicin (used for tuberculosis)" he added.
The country is experiencing a fresh wave of new COVID-19 cases most likely driven by the omicron variant.
The country is experiencing a fresh wave of new COVID-19 cases most likely driven by the omicron variant.
On Wednesday, Philippines confirmed nearly 23,000 fresh infections, pushing active cases to over 270,000.
On Wednesday, Philippines confirmed nearly 23,000 fresh infections, pushing active cases to over 270,000.
WATCH
Read More:
Food and Drug Administration
coronavirus
COVID19
molnupiravir
FDA
DOH
Molnarz
Paxlovid
COVID-19 treatment
COVID-19 drugs
ADVERTISEMENT
ADVERTISEMENT